Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares

Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares – NEWSnet – News… as it used to be